119 related articles for article (PubMed ID: 1966596)
41. Monoclonal antibodies against human esophageal carcinoma cell lines.
Hsieh HG; Hu CP; Han SH; Chen LR; Chien KY; Chou CK; Ting LP; Su TS; Huang MH; Hsu WH
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):179-89. PubMed ID: 2827967
[TBL] [Abstract][Full Text] [Related]
42. Induction of cytotoxic T lymphocytes from the peripheral blood of a hepatocellular carcinoma patient using melanoma antigen-1 (MAGE-1) peptide.
Lu J; Leng X; Peng J; Mou D; Pang X; Shang X; Chen W
Chin Med J (Engl); 2002 Jul; 115(7):1002-5. PubMed ID: 12150730
[TBL] [Abstract][Full Text] [Related]
43. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
Shouval D; Adler R
Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
[No Abstract] [Full Text] [Related]
44. [Expression of human hepatoma associated antigen in relation to the cell cycle].
Zhu XY
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):322-4. PubMed ID: 1664314
[TBL] [Abstract][Full Text] [Related]
45. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
46. Class I and class II major histocompatibility complex antigens expression on human hepatocytes and hepatoma cells: an approach with high sensitivity and specificity.
Chiu JH; Lui WY; Chang HM; Loong CC; Wu LH; Kao HL; Wu CW
Cytometry; 1997 Dec; 30(6):317-23. PubMed ID: 9440824
[TBL] [Abstract][Full Text] [Related]
47. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
Miyake M; Kohno N; Nudelman ED; Hakomori S
Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
[TBL] [Abstract][Full Text] [Related]
48. Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area.
Sideras K; Bots SJ; Biermann K; Sprengers D; Polak WG; IJzermans JN; de Man RA; Pan Q; Sleijfer S; Bruno MJ; Kwekkeboom J
Br J Cancer; 2015 Jun; 112(12):1911-20. PubMed ID: 26057582
[TBL] [Abstract][Full Text] [Related]
49. Identification of human hepatoma-defined cell surface molecules.
Moriarity DM; Fox N; Aden DP; Hoyer JR; Knowles BB
Hybridoma; 1983; 2(1):39-47. PubMed ID: 6205970
[TBL] [Abstract][Full Text] [Related]
50. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
[TBL] [Abstract][Full Text] [Related]
51. [Immunohistochemical observation of anti-human hepatocellular carcinoma monoclonal antibody HL2 in cancers].
Lin P; Xiao Y; Cao J; Zhang J; Lu Y; Huang X
Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):35-7. PubMed ID: 8070768
[TBL] [Abstract][Full Text] [Related]
52. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies.
Shouval D; Eilat D; Carlson RI; Adler R; Livni N; Wands JR
Hepatology; 1985; 5(3):347-56. PubMed ID: 2987098
[TBL] [Abstract][Full Text] [Related]
53. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
[TBL] [Abstract][Full Text] [Related]
54. Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies.
Chen X; Fu S; Chen F; Chen H; Chen Z
Oncol Rep; 2008 Oct; 20(4):979-85. PubMed ID: 18813843
[TBL] [Abstract][Full Text] [Related]
55. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
56. [Studies on immunohistochemical localization and immunotargeting of monoclonal antibody against human hepatocellular carcinoma].
Ji YY
Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):335-8. PubMed ID: 8174475
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies from mice bearing human colorectal carcinoma xenografts.
Sikora K; Warenius H
Med Oncol Tumor Pharmacother; 1986; 3(1):5-9. PubMed ID: 3702511
[TBL] [Abstract][Full Text] [Related]
58. Human monoclonal antibodies to nuclear antigens.
McKnight ME; Koda K; DeBoer K; Glassy MC
Hum Antibodies Hybridomas; 1990; 1(2):77-82. PubMed ID: 2103355
[TBL] [Abstract][Full Text] [Related]
59. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
60. [Diagnosis of hepatocellular carcinoma using chicken anti-monoclonal antibody--as tumor marker on the heterophilic hanganutziu-deicher antigen].
Koda T; Shimosakoda T; Nishinaka S; Asaoka H; Nakaba H; Tamura I; Matsuda H
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2771-7. PubMed ID: 7993113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
